# First US Bancshares, Inc.: overview FUSB · Nasdaq · CIK 717806 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fusb.md) · [Financials](/companies/fusb/financials.md) · [Filings](/companies/fusb/filings.md) · [Insiders](/companies/fusb/insiders.md) Latest reported revenue: [$277.0k](/filings/0001193125-26-337583.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001193125-26-337583). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [312](/filings/0001193125-25-268881.md) | [323 d](/filings/0001193125-26-103635.md) | [288](/filings/0001193125-26-211192.md) | [278](/filings/0001193125-26-337583.md) | [289](/filings/0001193125-25-268881.md) | [285 d](/filings/0001193125-26-103635.md) | [283](/filings/0001193125-26-211192.md) | [277](/filings/0001193125-26-337583.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [712.2%](/filings/0001193125-25-268881.md) | [530.7% d](/filings/0001193125-26-103635.md) | [615.3%](/filings/0001193125-26-211192.md) | [55.8%](/filings/0001193125-26-337583.md) | [669.9%](/filings/0001193125-25-268881.md) | [747.0% d](/filings/0001193125-26-103635.md) | [687.3%](/filings/0001193125-26-211192.md) | [632.9%](/filings/0001193125-26-337583.md) | | Diluted EPS | $ per share | [0.36](/filings/0001193125-26-103635.md) | [0.29](/filings/0001193125-26-103635.md) | [0.29](/filings/0001193125-26-211192.md) | [0.03](/filings/0001193125-26-337583.md) | [0.32](/filings/0001193125-26-103635.md) | [0.36](/filings/0001193125-26-103635.md) | [0.33](/filings/0001193125-26-211192.md) | [0.31](/filings/0001193125-26-337583.md) | | Free cash flow | $k | [1,276 d](/filings/0001193125-25-268881.md) | [2,179 d](/filings/0001193125-26-103635.md) | [1,685](/filings/0001193125-26-211192.md) | [1,647 d](/filings/0001193125-26-337583.md) | [3,603 d](/filings/0001193125-25-268881.md) | [2,149 d](/filings/0001193125-26-103635.md) | [3,629](/filings/0001193125-26-211192.md) | [(644) d](/filings/0001193125-26-337583.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [1.2](/filings/0000950170-24-031518.md) | [1.2](/filings/0000950170-25-039251.md) | [1.2](/filings/0001193125-26-103635.md) | [1.1](/filings/0001193125-26-103635.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | [594.8%](/filings/0000950170-24-031518.md) | [708.9%](/filings/0000950170-25-039251.md) | [663.1%](/filings/0001193125-26-103635.md) | [525.6%](/filings/0001193125-26-103635.md) | | Diluted EPS | $ per share | [0.66](/filings/0000950170-23-007191.md) | [1.06](/filings/0000950170-24-031518.md) | [1.33](/filings/0000950170-25-039251.md) | [1.33](/filings/0001193125-26-103635.md) | [1.00](/filings/0001193125-26-103635.md) | | Free cash flow | $m | [9.0](/filings/0000950170-23-007191.md) | [11.3](/filings/0000950170-24-031518.md) | [11.6](/filings/0000950170-25-039251.md) | [5.7](/filings/0001193125-26-103635.md) | [9.1](/filings/0001193125-26-103635.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fusb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [GENDELL JEFFREY L](/funds/1056581.md) | 2026-06-30 | $6.6m | 397,454 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.8m | 106,184 | | Added +12,533 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.3m | 79,321 | | Reduced −3,000 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $970.7k | 58,636 | | Added +1,657 | | [Pinnacle Holdings, LLC](/funds/1411784.md) | 2026-06-30 | $872.8k | 52,737 | | Reduced −135 | | [REGIONS FINANCIAL CORP](/funds/1281761.md) | 2026-06-30 | $823.6k | 49,766 | | Reduced −3,574 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $567.3k | 34,280 | | Reduced −12,263 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $547.1k | 33,060 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $514.3k | 31,074 | | Added +212 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $486.1k | 29,374 | | Added +4,600 | ## Recent filings [All 1,464 filings](/companies/fusb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-28 | 23:11 ET | [SCHEDULE 13D/A](/filings/0001654954-26-007974.md) | Ownership report, active investor, amended | 0001654954-26-007974 | | 2026-08-06 | 17:51 ET | [10-Q](/filings/0001193125-26-337583.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337583 | | 2026-07-29 | 20:25 ET | [8-K](/filings/0001193125-26-323809.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323809 | | 2026-07-29 | 20:20 ET | [8-K](/filings/0001193125-26-323778.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323778 | | 2026-05-07 | 16:45 ET | [10-Q](/filings/0001193125-26-211192.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211192 | | 2026-05-04 | 20:15 ET | [8-K](/filings/0001193125-26-204019.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-204019 | | 2026-04-29 | 20:25 ET | [8-K](/filings/0001193125-26-191811.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191811 | | 2026-04-29 | 20:20 ET | [8-K](/filings/0001193125-26-191713.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-191713 | | 2026-03-18 | 13:03 ET | [DEF 14A](/filings/0001193125-26-112728.md) | Proxy statement, period 2026-04-30 | 0001193125-26-112728 | | 2026-03-12 | 17:01 ET | [10-K](/filings/0001193125-26-103635.md) | Annual report, period 2025-12-31 | 0001193125-26-103635 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-103635.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/aaf5bacf-09fa-43df-9c25-e1fa9a5c3485) ## About the filer - CIK: 717806 - Tickers: FUSB - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.